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Abstract
Background: Timely rheumatologic referral and management are crucial for patients with potential inflammatory
arthritis. To meet this need, tools such as the early inflammatory arthritis (EIA) detection tool was developed and
has been evaluated in Western populations. The aims of this study were to translate the English version of the EIA
detection tool to Chinese and to determine its clinimetric properties in Taiwanese patients.
Methods: Twenty controls and 111 patients with established diagnosis of osteoarthritis, rheumatoid arthritis, systemic
autoimmune diseases, psoriatic arthritis, and ankylosing spondylitis were recruited from a regional hospital in south
Taiwan. Multivariate logistic regression analysis was used to evaluate the independent and significant variables associated
with diagnosis by rheumatologists. A prediction model was also developed for differentiating between patients with
inflammatory arthritis and those with non-inflammatory arthritis musculoskeletal conditions.
Results: The Chinese version of the EIA detection tool showed acceptable internal consistency (KR-20 coefficient 0.78)
and test-retest reliability (κ statistic ranged from 0.43 to 0.94). A prediction model consisting of three EIA detection tool
items (joint pain, swelling in hands or wrists, and ever been told to have rheumatoid arthritis) and sex was able to
differentiate inflammatory arthritis and non-inflammatory arthritis musculoskeletal conditions with a sensitivity of 0.84, a
specificity of 0.86, a positive predictive value of 0.92, and a negative predictive value of 0.76.
Conclusions: The Chinese version of the EIA detection tool showed good clinimetric properties in this study population
and it can be used to differentiate Taiwanese patients with inflammatory arthritis and non-inflammatory arthritis
musculoskeletal conditions.
Background
Timely rheumatologic referral and management are cru-
cial for patients with potential inflammatory arthritis.
Early initiation of disease modifying antirheumatic drug
(DMARD) has been shown to improve clinical and
radiographic outcomes in patients with rheumatoid arth-
ritis–the most common type of inflammatory arthritis
[1, 2]. Ideally, treatment should be initiated within 3 to
6 months of symptom onset to reduce joint destruction
[3], which would otherwise progress to functional dis-
ability with severe health and economic consequences
[4, 5]. However, a population-based study in Québec,
Canada showed that in 10,001 patients coded as incident
rheumatoid arthritis, only 27.3 % of them consulted a
rheumatologist within the next 2.5–3.5 years. Among
those who consulted, it took a median of 79 days from
the initial physician visit for rheumatoid arthritis to con-
sultation with a rheumatologist [6]. Our previous study
also showed that Taiwanese patients with rheumatoid
arthritis had increased ambulatory visits for musculo-
skeletal disorders several years before their definite diag-
nosis of rheumatoid arthritis [7].
To be able to initiate early treatment, patients need to
be identified at the earliest possible stage of their disease
with appropriate tools [8]. Currently, population-based
screening for preclinical phase of rheumatoid arthritis
based on autoantibodies’ and cytokines’ profiles are not
cost-effective due to its low prevalence. On the other
hand, identification of patients mostly like to have
rheumatoid arthritis at the primary care level for referral
to rheumatologists is warranted because clinical outcomes
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can be improved with early treatment initiation [9]. One
instrument for this identification purpose is the early in-
flammatory arthritis (EIA) detection tool, which is a 12-
item patient self-administered questionnaire with yes/no
questions on symptoms of arthritis, functional ability,
personal and family history of rheumatoid arthritis, a diag-
nosis of psoriasis, and whether the symptom duration was
between 6 and 52 weeks. The inflammatory arthritis
dimensions and constructs of the tool were identified
from a systematic review of the literature and a three-
round Delphi panel consensus [10]. A scoring algorithm
based on the EIA detection tool was also developed to
optimize the discriminative properties for inflammation
arthritis detection in rheumatology triage clinical settings.
The scoring algorithm showed a sensitivity of 0.86, a spe-
cificity of 0.87, and a receiver operating characteristic plot
area under the curve value of 0.92 [11]. A study of the
EIA detection tool on 39 patients with early inflammatory
arthritis, 43 with established inflammatory arthritis, 50
with non-inflammatory arthritis musculoskeletal condi-
tions, and 38 with non-musculoskeletal conditions dem-
onstrated good comprehensibility, internal consistency,
and test-retest reliability. A previously developed rheuma-
tology triage scoring algorithm, which includes age, sex,
EIA detection tool items 4 (trouble making a fist), 5
(morning stiffness), 9 (ever been told to have rheumatoid
arthritis), and 11 (psoriasis diagnosis) was able to differen-
tiate early inflammatory arthritis from the other three
groups, with a receiver operating characteristic plot area
under the curve value of 0.83 [12]. Given the promising
psychometric properties and clinical applications of the
EIA detection tool in Western populations, we trans-
lated the EIA detection tool into Chinese and assessed
its clinimetric properties in healthy controls and in
patients with established diagnosis of different muscu-
loskeletal disorders including osteoarthritis, rheumatoid
arthritis, systemic autoimmune diseases, psoriatic arth-
ritis, and ankylosing spondylitis.
Methods
Sample and data collection
The study was conducted from April 2014 to July 2014
in a regional hospital located in south Taiwan. Patients
with established diagnosis of musculoskeletal disorders
including osteoarthritis, rheumatoid arthritis, systemic
autoimmune diseases (systemic lupus erythematosus,
progressive systemic sclerosis, and Sjögren’s syndrome),
psoriatic arthritis, and ankylosing spondylitis in the out-
patient division of Allergy, Immunology and Rheumatol-
ogy were invited to participate in the study. We used
purposive recruitment to ensure that each rheumatic dis-
ease group, in addition to the control group and the osteo-
arthritis group, had at least 20 individuals. Participants
were asked to complete a questionnaire with questions on
age, sex, and a 12-item EIA detection tool in Chinese
(described below). The study protocol was reviewed
and approved by the institutional review board of the
Dalin Tzu Chi Hospital, Buddhist Tzu Chi Medical
Foundation, Taiwan (No. B10301018). All participants
gave written informed consent.
EIA detection tool
The EIA detection tool was originally developed by Bell
and colleagues [10] in Canada for EIA detection in pre-
primary care settings. Based on a literature review and a
three-round Dephi consensus panel of EIA experts and
stakeholders, an 11-question EIA detection tool suitable
for self-administration was developed. The 11 questions
capture seven dimensions of EIA detection, which in-
clude articular pain, swelling and stiffness, distribution
of joint involvement, function, and diagnostic and family
history of inflammatory arthritis. For early detection of
inflammatory arthritis, the tool should be used among
patients with at least 6 weeks but less than 52 weeks of
musculoskeletal symptoms.
Development of a Chinese version of EIA detection tool
Permission to translate and adapt the English version of
the EIA detection tool to Chinese was obtained from Dr.
Mary J. Bell of the original source. A forward and back-
ward process was applied to translate the EIA detection
tool from English into Chinese (in traditional Chinese
characters). Two independent physicians who were na-
tive Chinese speakers and fluent in English produced a
forward translation of the EIA detection tool with the
aim of conceptual rather than literal translation. Two
other bilingual physicians translated the provisional
Chinese questionnaire back into English. The original
English and back-translated English versions were com-
pared for discrepancies by two authors (MCL, MK). One
difference between the two versions that we decided to
keep was the wording in item 3. Instead of “hands or
wrists” in the original English version, we used the same
wording “wrists and hands (palms and fingers)” for
consistency, as in our item 2. The provisional Chinese
version of the questionnaire was used for further psy-
chometric testing.
The general comprehension of the provisional version
of the questionnaire was tested on five healthy individ-
uals with different educational levels. Based on the parts
that required clarification, we had made three additional
modifications. First, we changed item 7 “Are the same
joints involved on both sides of your body?” to “Are the
above pain or swollen conditions occur to the same
joints involved on both sides of your body?”. Second, the
concept of “leisure activities” was not intuitively under-
stood by some elderly without further elaboration. The
meaning of leisure activities also varies depending on the
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sex, age, and socioeconomic status of the respondents.
Therefore, the words “leisure activities” were substituted
by “other activities” in item 8. Third, we noted that a few
patients without psoriasis incorrectly responded to item
11. The reason for that confusion is because the Chinese
term for psoriasis contains a character that is also used for
dermatophytosis. Although we included two variants of
the Chinese term for psoriasis, both terms still contain
one of the Chinese characters for dermatophytosis. There
appears to be no simple way to correct this misnomer in
the Chinese term for psoriasis.
Statistical analysis
Comparisons of sex and age across control and rheum-
atic disease groups were performed using Fisher’s exact
test and non-parametric Kruskal-Wallis test, respect-
ively. Dunn-Sidak correction was applied to control for
the probability of Type I errors in pairwise comparisons.
Since item 12 is a measurement of symptom duration,
it was not included in the analysis of the clinimetric
properties of the Chinese EIA detection tool. An overall
score for the Chinese EIA detection tool for each respond-
ent was calculated by summing the yes responses of the
11 items and then standardized the total to a final score
with a range of 0 to 100. The differences across the
control and the five disease groups in the Chinese EIA
detection tool score were compared using the Kruskal
Wallis test. Mann–Whitney test with Dunn-Sidak correc-
tions were applied in the pairwise comparisons. The fre-
quency distribution of each of the 11 items across the
control and the five disease groups were compared using
Fisher’s exact test with Dunn-Sidak correction.
Internal consistency of the Chinese EIA detection tool
was examined using the Kuder-Richardson Formula 20
(KR-20), which is an equivalent of Cronbach’s alpha for
binary data. Test-retest reliability of the Chinese EIA de-
tection tool was estimated by kappa statistic, κ, which
tested for agreement with regard to the presence or ab-
sence of each of the Chinese EIA detection tool item
between the two time points. A mean washout period of
28 days (range 14–49 days) between the initial tool com-
pletion and the retesting was used.
A multivariate logistic regression analysis with likeli-
hood ratio backward selection procedure was used to
evaluate the independent and significant variables asso-
ciated with diagnosis by rheumatologists. The independ-
ent variables evaluated in the model included age, sex,
and the 11 items in the Chinese EIA detection tool.
The rheumatic disease groups were further combined into
two groups: an inflammatory arthritis group (rheumatoid
arthritis and psoriatic arthritis) and a non-inflammatory
arthritis musculoskeletal disorders group (osteoarthritis,
progressive systemic sclerosis, and Sjögren’s syndrome).
Ankylosing spondylitis was not included in either group
because the items in the original EIA detection tool were
not designed specifically for its detection. Systemic lupus
erythematosus was also not included because the arthritis
typically seen in it is very different from that observed in
rheumatoid arthritis. The independent and significant
variables associated with inflammatory arthritis versus
non-inflammatory arthritis were evaluated with multivari-
ate logistic regression analysis. The area under the receiver
operating characteristic curve was used to evaluate the
discriminative performance of the model. The Youden
index J (sensitivity + specificity −1) was used to determine
an optimal cut-off value. In addition, 95 % confidence
intervals for sensitivity, specificity, positive predictive
values, and negative predictive values were determined by
the Wilson score interval.
A two-tailed p value of <0.05 was considered statisti-
cally significant. All statistical analyses were conducted
using IBM SPSS Statistics software package, version 21.0
(IBM Corp., Armonk, NY, USA).
Results
A total of 131 participants were enrolled in the study.
The overall mean age was 51.6 years and 38.2 % of them
were males. The age and sex distribution among the six
groups are shown in Table 1. The mean ages of osteo-
arthritis (65.4 years) and rheumatoid arthritis (57.3 years)
were significantly older than that of the controls
(42.4 years). There were significantly more male partici-
pants in the ankylosing spondylitis group compared with
the rheumatoid arthritis group, the osteoarthritis group,
and the systemic autoimmune diseases group (progressive
systemic sclerosis, Sjögren’s syndrome, and systemic lupus
erythematosus).
The 11 items of the Chinese EIA detection tool showed
an acceptable internal consistency (KR-20 coefficient 0.78),
indicating that this tool is a reasonably reliable instrument
in producing consistent scores. As shown in Table 2, the κ
statistic for assessing test-retest reliability ranged from 0.43
to 0.94.
Table 3 shows the Chinese EIA detection tool scores
and the frequencies of presence of each item across the
six groups. The median value of the score was the lowest,
as expected, in the control group and was the highest in
the rheumatoid arthritis group. The median value of the
Chinese EIA detection tool score for rheumatoid arthritis
was significantly higher than that of the control, systemic
autoimmune diseases group (progressive systemic scler-
osis, Sjögren’s syndrome, and systemic lupus erythemato-
sus), and ankylosing spondylitis. The median value of the
Chinese EIA detection tool score for osteoarthritis was
not significantly different from the other groups except
that of the controls. The frequencies of presence of the 11
items were significantly different across the groups for all
of them except in item 6 and item 10.
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Table 4 shows the significant and independent factors
associated with osteoarthritis, each of the four groups of
rheumatic diseases, and control. Age was a significant
and independent factor associated with control, rheuma-
toid arthritis, osteoarthritis, and ankylosing spondylitis.
Male sex was associated with ankylosing spondylitis.
Item 1 of the Chinese EIA detection tool (joint pain)
was associated directly with osteoarthritis but inversely
with the control group. Item 2 (hand/wrist pain) was as-
sociated directly with psoriatic arthritis but inversely
with ankylosing spondylitis. Item 3 (hand/wrist swelling)
was associated directly with rheumatoid arthritis but
inversely with osteoarthritis. Item 5 (morning stiffness)
was associated directly with ankylosing spondylitis but
inversely with the control group. Item 6 (morning stiffness
duration >60 min) was associated directly only with psori-
atic arthritis. Item 8 (functional difficulty) was inversely
associated with systemic autoimmune diseases. Item 9
(ever been told to have rheumatoid arthritis) was associ-
ated directly with rheumatoid arthritis but inversely with
psoriatic arthritis. Finally, item 11 (psoriasis diagnosis)
was associated inversely with the control group.
Table 5 shows the results of the multivariate logistic
regression model of inflammatory arthritis versus non-
inflammatory arthritis musculoskeletal disorders. Four
items emerged as significant and independent factors
and they included sex (adjusted OR = 6.94, p = 0.008),
item 1 (joint pain) (adjusted OR = 0.23, p = 0.046), item
3 (hand/wrist swelling) (adjusted OR = 8.88, p = 0.004),
and item 9 (ever been told to have rheumatoid arthritis)
(adjusted OR = 16.38, p < 0.001). Using the Youden
index-optimized cut-off point of 0.60 to rescale the
threshold to 0, the logistic regression equation results in
the following formula:
inflammatory arthritis ¼ –1:28þ 1:94 sexð Þ
– 1:45 item 1ð Þ
þ 2:18 item 3ð Þ
þ 2:80 item 9ð Þ
In this formula, the item variable takes on the value
“1” if the response is yes and the value “0” if the re-
sponse is no. For the variable sex, it takes on the value
“1” for males and “0” for females. With the rescaling of
the logistic regression equation, a positive result predicts
an inflammatory arthritis case while a negative result
predicts a non-inflammatory arthritis case. Regarding
the prediction performance of the model, based on the
Youden index-optimized cut-off value of 0.60, the model
Table 1 Demographic characteristic of participants (N = 131)
Variable Total Group p
Control Rheumatoid arthritis Osteoarthritis SAD Psoriatic arthritis Ankylosing spondylitis
131 (100) 20 (15.3) 31 (23.7) 20 (15.3) 20 (15.3) 20 (15.3) 20 (15.3)
Age (years) <0.001
Mean (SD) 51.6 (15.1) 42.4 (14.5)a 57.3 (14.9)b 65.4 (10.2)b 47.2 (12.4)abc 49.5 (11.9)abc 44.6 (13.7)abc
Sex <0.001
Male 50 (38.2) 7 (35)abc 7 (23)ab 5 (25)ab 3 (15)ab 12 (60)abc 16 (80)c
Female 81 (61.8) 13(65) 24 (77) 15 (75) 17 (85) 8 (40) 4 (20)
Age across groups were compared using non-parametric Kruskal-Wallis test and Mann–Whitney test with Dunn-Sidak adjustment was applied to control for the
probability of Type I errors in pairwise comparisons
Sex distribution across groups were compared using Fisher’s exact test and Dunn-Sidak adjustment was applied in the pairwise comparisons
SAD systemic autoimmune diseases including progressive systemic sclerosis, Sjögren’s syndrome, and systemic lupus erythematosus
Figures with different superscript were significantly different at p < 0.05
Table 2 Test-retest reliability (κ statistic) of the 11 items in the
Chinese version of the Early Inflammatory Arthritis detection
tool (N = 74)
Item Test-retest reliability
κ statistic (95 % CI)
1. Do you have pain in your joints? 0.73 (0.57–0.89)
2. Do you have pain in your wrists
and hands?
0.67 (0.50–0.84)
3. Are your hands or wrists swollen? 0.42 (0.24–0.60)
4. Do you have trouble making a fist? 0.53 (0.27–0.79)
5. Are your joints stiff in the morning? 0.76 (0.61–0.91)
6. From the time you wake in the
morning, does it take more than
60 min for your joints to move
more freely?
0.47 (0.16–0.78)
7. Are the same joints involved on
both sides of your body?
0.76 (0.60–0.92)
8. Have important activities in your
life been affected because of bone
or joint problems, such as having
difficulty with personal care or
having to make a change regarding
leisure or work activities?
0.55 (0.35–0.76)
9. Have you ever been told that you
have rheumatoid arthritis?
0.81 (0.67–0.94)
10. Does anyone in your family have
rheumatoid arthritis?
0.94 (0.82–1.00)
11. Have you been diagnosed with
a rash called psoriasis?
0.86 (0.72–1.00)
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had a sensitivity of 0.84 and a specificity of 0.86 with a
positive predictive value of 0.92 and a negative predictive
value of 0.76.
Discussion
The main aim of this study was to translate the English
version of the EIA detection tool to Chinese and exam-
ine its clinimetric properties. Overall, the Chinese EIA
detection tool showed an acceptable internal consistency
and a reasonably satisfactory test-retest reliability. The
EIA detection tool was previously translated and adapted
for screening of early inflammatory arthritis in Arabic-
speaking populations. In a study of 30 patients, the in-
ternal consistency showed an acceptable value of KR-20
of 0.87. The Spearman’s rank correlations between the
Arabic EIA detection tool score was 0.90 with pain score
and 0.80 with Disease Activity Score 28 [13]. We noted
that the κ statistic value over the Chinese EIA detection
tool item 3 (hand/wrist swelling), item 4 (trouble making
a fist), item 6 (morning stiffness >60 min), and item 8
(functional difficulty) were all less than 0.6. Due to the
majority of population were out-patients with musculo-
skeletal disorders, these inconsistencies may reflect the im-
provement after receiving medical treatment. In addition,
the test-retest period, ranged from 14 to 49 days, used in
this study is longer than the typical 2-week interval in test-
retest studies. This may account for the lower reliability in
some of the items in the Chinese EIA detection tool com-
pared with the original tool [12].
In addition to focus on the clinimetric properties of
the Chinese EIA detection tool on patients with rheuma-
toid arthritis, the present study also included patients
with established diagnosis of osteoarthritis, ankylosing
spondylitis, and systemic autoimmune diseases, which
are common causes of joint pain often encountered in
rheumatology clinics. Several points worth mentioning
Table 3 Frequency of presence of conditions in the Chinese version of the Early Inflammatory Arthritis detection tool (N = 131)
Score or item Group p
Frequency (%)
Control Rheumatoid arthritis Osteoarthritis SAD Psoriatic arthritis Ankylosing spondylitis
20 (15) 31 (24) 20 (15) 20 (15) 20 (15) 20 (15)
Chinese EIA detection tool score 3.2 (6.1) 47.8 (22.4) 30.0 (14.8) 22.7 (25.5) 44.1 (22.7) 27.3 (16.7) <0.001
Mean (S. D.) [median,
minimum, maximum]
[0, 0, 18]a [46, 9, 91]b [27, 9, 55]bd [9, 0, 91]cd [46, 9, 82]bc [27, 0, 64]cd
1. Do you have pain in your joints? 2 (10)a 24 (78)bc 19 (95)c 8 (40)ab 13 (65)bc 12 (60)bc <0.001
2. Do you have pain in your wrists
and hands?
1 (5)a 20 (65)bc 6 (30)ac 8 (40)ac 13 (65)bc 4 (20)ac <0.001
3. Are your hands or wrists swollen? 0 (0)a 17 (55)b 2 (10)ac 5 (25)abc 9 (45)bc 1 (5)ac <0.001
4. Do you have trouble making a fist? 0 (0) 11 (36) 2 (10) 3 (15) 4 (20) 2 (10) 0.020
5. Are your joints stiff in the morning? 1 (5)a 18 (58)b 12 (60)b 10 (50)b 13 (65)b 15 (75)b <0.001
6. From the time you wake in the
morning, does it take more than
60 min for your joints to move
more freely?
0 (0) 5 (16) 1 (5) 1 (5) 5 (25) 2 (10) 0.123
7. Are the same joints involved
on both sides of your body?
0 (0)a 14 (45)bc 9 (45)bc 5 (25)ac 7 (35)ac 8 (40)bc 0.003
8. Have important activities in
your life been affected because
of bone or joint problems, such
as having difficulty with personal
care or having to make a change
regarding leisure or work activities?
2 (10)a 17 (55)bc 9 (45)ac 1 (5)a 8 (40)ac 7 (35)ac 0.001
9. Have you ever been told that
you have rheumatoid arthritis?
0 (0)a 29 (94)b 3 (15)a 4 (20)a 3 (15)a 4 (20)a <0.001
10. Does anyone in your family
have rheumatoid arthritis?
0 (0) 5 (16) 3 (15) 4 (20) 3 (15) 3 (15) 0.421
11. Have you been diagnosed
with a rash called psoriasis?
1 (5)a 3 (10)a 0 (0)a 1 (5)a 19 (95)b 2 (10)a <0.001
Chinese EIA detection tool score = sum of yes response in item 1 to 11, standardized to a range of 0 to 100
The Chinese EIA detection tool scores across groups were compared with non-parametric Kruskal-Wallis test and Mann–Whitney test with Dunn-Sidak correction
was applied to control for the probability of Type I errors in pairwise comparisons
SAD systemic autoimmune diseases including progressive systemic sclerosis, Sjögren’s syndrome, and systemic lupus erythematosus
Figures with different superscript were significantly different at p < 0.05, adjusting for multiple comparisons with Dunn-Sidak correction
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Table 4 Multivariate logistic regression analyses of control, rheumatoid arthritis, osteoarthritis, systemic autoimmune diseases, psoriatic arthritis, and ankylosing spondylitis (N = 131)
Variable Group
odds ratio (95 % confidence interval)
Control Rheumatoid arthritis Osteoarthritis SAD Psoriatic arthritis Ankylosing spondylitis
Age (per 10 years) 0.56 (0.35–0.92) 1.62 (1.03–2.55) 2.46 (1.46–4.14) – – 0.67 (0.45–0.98)
Sex (females as reference group) – – – – – 7.43 (2.16–25.66)
1. Do you have pain in your joints? 0.11 (0.02–0.58) – 19.47 (2.33–163.06) – – –
2. Do you have pain in your wrists and hands? – – – – 8.34 (2.56–27.23) 0.17 (0.04–0.66)
3. Are your hands or wrists swollen? – 5.26 (1.34–20.7) 0.10 (0.02–0.55) – – –
4. Do you have trouble making a fist? – – – – – –
5. Are your joints stiff in the morning? 0.04 (0.01–0.38) – – – – 5.19 (1.41–19.04)
6. From the time you wake in the morning, does it take more than
60 min for your joints to move more freely?
– – – – 11.05 (2.18–56.08) –
7. Are the same joints involved on both sides of your body? – – – – – –
8. Have important activities in your life been affected because of
bone or joint problems, such as having difficulty with personal
care or having to make a change regarding leisure or work activities?
– – – 0.08 (0.01–0.64) – –
9. Have you ever been told that you have rheumatoid arthritis? – 93.45 (17.73–492.53) – – 0.05 (0.01–0.32) –
10. Does anyone in your family have rheumatoid arthritis? – – – – – –
11. Have you been diagnosed with a rash called psoriasis? 0.10 (0.01–0.98) – – – – –
Nagelkerke R2 0.54 0.69 0.47 0.14 0.30 0.38













regarding the results of the multivariate logistic regres-
sion analyses of the independent Chinese EIA detection
tool items associated patients with the musculoskeletal
disorders (Table 4). As expected, item 9 (ever been told
to have rheumatoid arthritis) was strongly associated
with the rheumatoid arthritis group. In addition, hand/
wrist swelling was significantly associated with the
rheumatoid arthritis group but inversely associated with
the osteoarthritis group. This item could be useful clinic-
ally for differentiating these two diseases.
Furthermore, we noted that Chinese EIA detection tool
item 4, item 7, and item 10 were not associated with any
clinical conditions. In item 4 (trouble make a fist), this item
was reported to be a useful indicator in one study [11] but
failed to do so in another study [12]. Regarding the sym-
metry of the affected joints (item 7), it should be noted that
although symmetry is one of the clinical presentation ac-
cording to the 1987 American College of Rheumatology
classification criteria for rheumatoid arthritis [14], it was
dropped from the 2010 American College of Rheumatol-
ogy (ACR) and the European League Against Rheumatism
(EULAR) Rheumatoid Arthritis Classification Criteria [15].
Findings from our study support this change. For item 10,
although a family history of rheumatoid arthritis is known
to be a strong risk factor for developing rheumatoid arth-
ritis [16], it did not emerge as a significant factor in any of
our prediction models. In our sample, 16 % of the patients
with rheumatoid arthritis had a family history of rheuma-
toid arthritis, but 15–20 % of the patients with musculo-
skeletal disorders other than rheumatoid arthritis also had
a family history of rheumatoid arthritis. In a study on the
measurement properties of the EIA detection tool, the pro-
portions of participants with a family history of rheumatoid
arthritis ranged from approximately 16–34 % and were not
significantly different among participants with early in-
flammatory arthritis, established inflammatory arthritis,
non-inflammatory arthritis musculoskeletal conditions, and
non-musculoskeletal conditions [12]. In addition, a register-
based Swedish study showed that less than 3 % of the
patients with rheumatoid arthritis had a first-degree relative
diagnosed with rheumatoid arthritis [17]. Therefore, the
relatively high proportion of patients with rheumatoid arth-
ritis reported to have family member with rheumatoid arth-
ritis is likely to be an overestimation as a result of family
information bias [18].
The Chinese EIA detection tool could be useful for pa-
tients with ankylosing spondylitis and systemic auto-
immune diseases (progressive systemic sclerosis, Sjögren’s
syndrome, and systemic lupus erythematosus) because
these diseases are often associated with joint pain and they
need to be differentiated from inflammatory arthritis. As
shown in Table 3, although both patients with inflamma-
tory arthritis and systemic autoimmune diseases have
similar elevated proportion of joint pain (accessed with
item 1 and item 2) and morning stiffness (accessed with
item 5), patients with systemic autoimmune diseases did
not have increased functional difficulty (accessed with
item 8). These findings are consistent with clinical obser-
vation that arthralgia is the main complaint of patients
with systemic autoimmune diseases. Regarding ankylosing
spondylitis, the Chinese EIA detection tool item 5 (Are
you joints stiff in the morning?) was significantly associ-
ated with ankylosing spondylitis (Table 4). This result is
consistent with the typical symptom of spine stiffness in
the morning among patients ankylosing spondylitis. Al-
though not specifically designed for, the Chinese EIA detec-
tion tool was able to differentiate patients with ankylosing
spondylitis from the other conditions. It is likely that
patients with ankylosing spondylitis interpreted the words
“joints stiff” in item 5 as spine stiffness. Overall, the Chinese
EIA detection tool appeared to be able to discriminate
osteoarthritis, rheumatoid arthritis, psoriatic arthritis, and
ankylosing spondylitis in our clinical sample.
Furthermore, a prediction model based on multivariate
logistic regression analysis was developed with the dis-
eases classified as either inflammatory arthritis or non-
inflammatory arthritis (Table 5). The final model with four
variables had an area under the receiver-operating
Table 5 A prediction model of inflammatory arthritis versus
non-inflammatory arthritis musculoskeletal disorders (N = 80)
Variable in the prediction model
of inflammatory arthritis versus
non-inflammatory arthritis
odds ratio (95 % CI) p value
Sex (female as reference group) 6.94 (1.66–29.08) 0.008
1. Do you have pain in your joints? 0.23 (0.06–0.98) 0.046
3. Are your hands or wrists swollen? 8.88 (2.04–38.59) 0.004
9. Have you ever been told that
you have rheumatoid arthritis?
16.38 (3.93–68.30) <0.001
Intercept of the model (β coefficient) −0.64 –
Nagelkerke R2 0.529 –
Performance parameter of the
prediction model
Area under the ROC curve (95 % CI) 0.88 (0.80–0.96)
Optimal cut-off point 0.60
Youden index J 0.71
Sensitivity (95 % CI) 0.84 (0.71–0.93)
Specificity (95 % CI) 0.86 (0.68–0.96)
Positive predictive value (95 % CI) 0.92 (0.79–0.97)
Negative predictive value (95 % CI) 0.76 (0.57–0.88)
The inflammatory arthritis group consisted of rheumatoid arthritis and
psoriatic arthritis. The non-inflammatory arthritis musculoskeletal disorders
group consisted of osteoarthritis, progressive systemic sclerosis, and
Sjögren’s syndrome
Age, sex, and all 11 items of the Chinese EIA detection tool were evaluated in
the multivariate logistic regression analysis
95 % CI: 95 % confidence interval; ROC: receiver operating characteristic
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characteristic curve of 0.88, indicating the model could ac-
curately predict inflammatory arthritis. Our regression
models were different from that reported by Tavares and
colleagues [11], which could be explained by the differ-
ences in the study sample. We compared the patients with
established diagnosis of inflammatory arthritis and non-
inflammatory arthritis musculoskeletal disorders, with the
latter group containing patients with osteoarthritis, pro-
gressive systemic sclerosis, and Sjögren’s syndrome. On
the other hand, Tavares and colleagues [11] compared pa-
tients with inflammatory arthritis and non-inflammatory
arthritis who were referred to rheumatologic care. There-
fore, depending on the characteristics of the clinical
setting, different prediction models may have to be devel-
oped accordingly.
Our study presents some limitations that deserve
comment. First, all our patients already had established
diagnosis of various musculoskeletal disorders for sev-
eral years. Therefore, their responses to the items of
the Chinese EIA detection tool might be affected by the
duration of their diseases. Nevertheless, our results pro-
vided support for the usefulness of the tool in differentiat-
ing inflammatory arthritis versus non-inflammatory
arthritis musculoskeletal conditions. Continued research
is needed to establish the clinical utility of the Chinese
EIA detection tool in patients at the early stage of their
disease. The original English EIA detection tool is recom-
mended for use among patients with at least 6 weeks but
less than 52 weeks of musculoskeletal symptoms. Second,
a culture difference exists as some patients were confused
between the diagnosis of psoriasis and dermatophytosis.
Third, the disease activity of our patients could be affected
by their medication treatment. Nevertheless, our patients
still exhibited clinical signs that are typical of their re-
spective diseases.
Conclusions
This study showed that the Chinese EIA detection tool
has an acceptable internal consistency and is reasonably
reliable. The full Chinese EIA detection tool appeared to
be able to differentiate osteoarthritis, rheumatoid arthritis,
psoriatic arthritis, and ankylosing spondylitis among each
other. In addition, a multivariate logistic regression model
based on three items of the Chinese EIA detection tool
and sex was developed for differentiating inflammatory
arthritis versus non-inflammatory arthritis musculoskel-
etal conditions with good prediction performance.
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